Terms: = Uterine cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
5 results:
1. Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study.
Zhang G; Nie F; Zhao W; Han P; Wen J; Cheng X; Wu W; Liu Q; Sun Y; Wang Y; Liu Y; Ren F
World J Surg Oncol; 2023 Nov; 21(1):357. PubMed ID: 37986077
[TBL] [Abstract] [Full Text] [Related]
2. Reanalysis of single-cell data reveals macrophage subsets associated with the immunotherapy response and prognosis of patients with endometrial cancer.
Wu Q; Jiang G; Sun Y; Li B
Exp Cell Res; 2023 Sep; 430(2):113736. PubMed ID: 37541419
[TBL] [Abstract] [Full Text] [Related]
3. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Ma J; Zhang JK; Yang D; Ma XX
Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
[TBL] [Abstract] [Full Text] [Related]
4. Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical cancer Progression.
Liu P; Iden M; Fye S; Huang YW; Hopp E; Chu C; Lu Y; Rader JS
Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):642-650. PubMed ID: 28069683
[No Abstract] [Full Text] [Related]
5. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
Fu ZC; Wang FM; Cai JM
Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
[TBL] [Abstract] [Full Text] [Related]
